Heart drug delivery method tested in 150 patients
NCT ID NCT01080638
First seen May 16, 2026 · Last updated May 16, 2026
Summary
This study looked at whether giving the blood thinner abciximab directly into the heart artery works as well as giving it through a vein followed by a 12-hour drip. The goal was to reduce heart muscle damage in people having a first non-ST elevation heart attack. The study was stopped early and involved 150 adults who needed angioplasty.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Internal Medicine, Cardiovascular Center, Seoul National University Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.